Abstract
Heterogeneity is recognized as a major barrier in efforts to improve the care and outcomes of patients with traumatic brain injury (TBI). Even within the narrower stratum of moderate and severe TBI, current management approaches do not capture the complexity of this condition characterized by manifold clinical, anatomical, and pathophysiologic features. One approach to heterogeneity may be to resolve undifferentiated TBI populations into endotypes, subclasses that are distinguished by shared biological characteristics. The endotype paradigm has been explored in a range of medical domains, including psychiatry, oncology, immunology, and pulmonology. In intensive care, endotypes are being investigated for syndromes such as sepsis and acute respiratory distress syndrome. This review provides an overview of the endotype paradigm as well as some of its methods and use cases. A conceptual framework is proposed for endotype research in moderate and severe TBI, together with a scientific road map for endotype discovery and validation in this population.
Similar content being viewed by others
References
Khellaf A, Khan DZ, Helmy A. Recent advances in traumatic brain injury. J Neurol. 2019;266(11):2878–89. https://doi.org/10.1007/s00415-019-09541-4.
Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1080–97. https://doi.org/10.3171/2017.10.JNS17352.
Taylor CA, Bell JM, Breiding MJ, Xu L. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. MMWR Surveill Summ. 2017;66(9):1–16.
Wright DW, Yeatts SD, Silbergleit R, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014;371(26):2457–66. https://doi.org/10.1056/NEJMoa1404304.
Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371(26):2467–76. https://doi.org/10.1056/NEJMoa1411090.
Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375(12):1119–30. https://doi.org/10.1056/NEJMoa1605215.
Andrews PJD, Sinclair HL, Rodriguez A, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373(25):2403–12. https://doi.org/10.1056/NEJMoa1507581.
Zafar SN, Khan AA, Ghauri AA, Shamim MS. Phenytoin versus leviteracetam for seizure prophylaxis after brain injury—a meta analysis. BMC Neurol. 2012;12:30. https://doi.org/10.1186/1471-2377-12-30.
Cooper DJ, Nichol AD, Bailey M, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR Randomized Clinical Trial. JAMA. 2018;320(21):2211–20. https://doi.org/10.1001/jama.2018.17075.
Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364(16):1493–502. https://doi.org/10.1056/NEJMoa1102077.
Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367(26):2471–81. https://doi.org/10.1056/NEJMoa1207363.
Luo P, Li X, Wu X, et al. Preso regulates NMDA receptor-mediated excitotoxicity via modulating nitric oxide and calcium responses after traumatic brain injury. Cell Death Dis. 2019;10(7):1–14. https://doi.org/10.1038/s41419-019-1731-x.
Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4–9. https://doi.org/10.1093/bja/aem131.
Menon DK, Schwab K, Wright DW, Maas AI. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil. 2010;91(11):1637–40. https://doi.org/10.1016/j.apmr.2010.05.017.
Varadhan R, Segal JB, Boyd CM, Wu AW, Weiss CO. A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research. J Clin Epidemiol. 2013;66(8):818–25. https://doi.org/10.1016/j.jclinepi.2013.02.009.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4. https://doi.org/10.1016/s0140-6736(74)91639-0.
Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008;5(8):e165. https://doi.org/10.1371/journal.pmed.0050165.
MRC CRASH Trial Collaborators, Perel P, Arango M, et al. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ. 2008;336(7641):425–429. https://doi.org/10.1136/bmj.39461.643438.25
Carney N, Totten AM, O’Reilly C, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition. Neurosurgery. 2017;80(1):6–15. https://doi.org/10.1227/NEU.0000000000001432.
Brennan PM, Murray GD, Teasdale GM. Simplifying the use of prognostic information in traumatic brain injury. Part 1: the GCS-Pupils score: an extended index of clinical severity. J Neurosurg. 2018;128(6):1612–20. https://doi.org/10.3171/2017.12.JNS172780.
Silverberg ND, Iaccarino MA, Panenka WJ, et al. Management of concussion and mild traumatic brain injury: a synthesis of practice guidelines. Arch Phys Med Rehabil. 2020;101(2):382–93. https://doi.org/10.1016/j.apmr.2019.10.179.
Reddy K, Sinha P, O’Kane CM, Gordon AC, Calfee CS, McAuley DF. Subphenotypes in critical care: translation into clinical practice. Lancet Respir Med. 2020;8(6):631–43. https://doi.org/10.1016/S2213-2600(20)30124-7.
Kuruvilla ME, Lee FEH, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clinic Rev Allerg Immunol. 2019;56(2):219–33. https://doi.org/10.1007/s12016-018-8712-1.
Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636–45. https://doi.org/10.1176/appi.ajp.160.4.636.
Agache I, Akdis CA. Endotypes of allergic diseases and asthma: an important step in building blocks for the future of precision medicine. Allergol Int. 2016;65(3):243–52. https://doi.org/10.1016/j.alit.2016.04.011.
Steyerberg EW, Wiegers E, Sewalt C, et al. Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019;18(10):923–34. https://doi.org/10.1016/S1474-4422(19)30232-7.
Wenzel SE, Schwartz LB, Langmack EL, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999;160(3):1001–8. https://doi.org/10.1164/ajrccm.160.3.9812110.
Svenningsen S, Nair P. Asthma endotypes and an overview of targeted therapy for asthma. Front Med (Lausanne). 2017;4:158. https://doi.org/10.3389/fmed.2017.00158.
Santus P, Saad M, Damiani G, Patella V, Radovanovic D. Current and future targeted therapies for severe asthma: managing treatment with biologics based on phenotypes and biomarkers. Pharmacol Res. 2019;146:104296. https://doi.org/10.1016/j.phrs.2019.104296.
Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198–207. https://doi.org/10.1056/NEJMoa1403290.
Genkel VV, Shaposhnik II. Conceptualization of heterogeneity of chronic diseases and atherosclerosis as a pathway to precision medicine: endophenotype, endotype, and residual cardiovascular risk. Int J Chronic Dis. 2020;2020:5950813. https://doi.org/10.1155/2020/5950813.
Battaglia M, Ahmed S, Anderson MS, et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care. 2020;43(1):5–12. https://doi.org/10.2337/dc19-0880.
Tromp J, Ouwerkerk W, Demissei BG, et al. Novel endotypes in heart failure: effects on guideline-directed medical therapy. Eur Heart J. 2018;39(48):4269–76. https://doi.org/10.1093/eurheartj/ehy712.
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–5. https://doi.org/10.1056/NEJMp1500523.
DiNardo AR, Nishiguchi T, Grimm SL, et al. Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021;2(3):217–32. https://doi.org/10.1016/j.medj.2020.11.003.
Shah PP, Franke JL, Medikonda R, et al. Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy. J Neurosurg. Published online June 4, 2021:1–11. https://doi.org/10.3171/2020.10.JNS201787
Sinha P, Delucchi KL, McAuley DF, O’Kane CM, Matthay MA, Calfee CS. Development and validation of parsimonious algorithms to classify ARDS phenotypes: secondary analyses of randomised controlled trials. Lancet Respir Med. 2020;8(3):247–57. https://doi.org/10.1016/S2213-2600(19)30369-8.
Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195(3):331–8. https://doi.org/10.1164/rccm.201603-0645OC.
Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–20. https://doi.org/10.1016/S2213-2600(14)70097-9.
McAuley DF, Laffey JG, O’Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371(18):1695–703. https://doi.org/10.1056/NEJMoa1403285.
Calfee CS, Delucchi KL, Sinha P, et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6(9):691–8. https://doi.org/10.1016/S2213-2600(18)30177-2.
Seymour CW, Gomez H, Chang CCH, et al. Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Crit Care. 2017;21:257. https://doi.org/10.1186/s13054-017-1836-5.
Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu VX. Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am J Respir Crit Care Med. 2016;194(2):147–55. https://doi.org/10.1164/rccm.201512-2544CP.
Leligdowicz A, Matthay MA. Heterogeneity in sepsis: new biological evidence with clinical applications. Crit Care. 2019;23:80. https://doi.org/10.1186/s13054-019-2372-2.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. https://doi.org/10.1001/jama.2016.0287.
DeMerle KM, Angus DC, Baillie JK, et al. Sepsis subclasses: a framework for development and interpretation. Crit Care Med. 2021;49(5):748–59. https://doi.org/10.1097/CCM.0000000000004842.
Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4(4):259–71. https://doi.org/10.1016/S2213-2600(16)00046-1.
Antcliffe DB, Burnham KL, Al-Beidh F, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199(8):980–6. https://doi.org/10.1164/rccm.201807-1419OC.
Antcliffe DB, Gordon AC. Why understanding sepsis endotypes is important for steroid trials in septic shock. Crit Care Med. 2019;47(12):1782–4. https://doi.org/10.1097/CCM.0000000000003833.
Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46(6):915–25. https://doi.org/10.1097/CCM.0000000000003084.
Girard TD, Thompson JL, Pandharipande PP, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med. 2018;6(3):213–22. https://doi.org/10.1016/S2213-2600(18)30062-6.
Sinha P, Delucchi KL, Chen Y, et al. Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study. Thorax. Published online July 12, 2021:thoraxjnl-2021–217158. https://doi.org/10.1136/thoraxjnl-2021-217158
Sinha P, Calfee CS, Delucchi KL. Practitioner’s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63–79. https://doi.org/10.1097/CCM.0000000000004710.
Kondziella D, Menon DK, Helbok R, et al. A precision medicine framework for classifying patients with disorders of consciousness: advanced classification of consciousness endotypes (ACCESS). Neurocrit Care. 2021;35(Suppl 1):27–36. https://doi.org/10.1007/s12028-021-01246-9.
Sandsmark DK, Bashir A, Wellington CL, Diaz-Arrastia R. Cerebral microvascular injury: a potentially treatable endophenotype of traumatic brain injury-induced neurodegeneration. Neuron. 2019;103(3):367–79. https://doi.org/10.1016/j.neuron.2019.06.002.
Dhar R, Falcone GJ, Chen Y, et al. Deep learning for automated measurement of hemorrhage and perihematomal edema in supratentorial intracerebral hemorrhage. Stroke. 2020;51(2):648–51. https://doi.org/10.1161/STROKEAHA.119.027657.
Nielson JL, Cooper SR, Yue JK, et al. Uncovering precision phenotype-biomarker associations in traumatic brain injury using topological data analysis. PLoS ONE. 2017;12(3):e0169490. https://doi.org/10.1371/journal.pone.0169490.
Huibregtse ME, Bazarian JJ, Shultz SR, Kawata K. The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury. Neurosci Biobehav Rev. 2021;130:433–47. https://doi.org/10.1016/j.neubiorev.2021.08.029.
Jahns FP, Miroz JP, Messerer M, et al. Quantitative pupillometry for the monitoring of intracranial hypertension in patients with severe traumatic brain injury. Crit Care. 2019;23(1):155. https://doi.org/10.1186/s13054-019-2436-3.
Haveman ME, Van Putten MJAM, Hom HW, Eertman-Meyer CJ, Beishuizen A, Tjepkema-Cloostermans MC. Predicting outcome in patients with moderate to severe traumatic brain injury using electroencephalography. Crit Care. 2019;23(1):401. https://doi.org/10.1186/s13054-019-2656-6.
Lee H, Mizrahi MA, Hartings JA, et al. Continuous electroencephalography after moderate to severe traumatic brain injury. Crit Care Med. 2019;47(4):574–82. https://doi.org/10.1097/CCM.0000000000003639.
Jha RM, Elmer J, Zusman BE, et al. Intracranial pressure trajectories: a novel approach to informing severe traumatic brain injury Phenotypes. Crit Care Med. 2018;46(11):1792–802. https://doi.org/10.1097/CCM.0000000000003361.
Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178. https://doi.org/10.1038/sdata.2018.178.
Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035. https://doi.org/10.1038/sdata.2016.35.
Yue JK, Vassar MJ, Lingsma HF, et al. Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J Neurotrauma. 2013;30(22):1831–44. https://doi.org/10.1089/neu.2013.2970.
Maas AIR, Menon DK, Steyerberg EW, et al. Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study. Neurosurgery. 2015;76(1):67–80. https://doi.org/10.1227/NEU.0000000000000575.
Bowman K, Matney C, Berwick DM. Improving Traumatic Brain Injury Care and Research: A Report From the National Academies of Sciences, Engineering, and Medicine. JAMA. 2022;327(5):419–20. https://doi.org/10.1001/jama.2022.0089.
Bhatraju PK, Zelnick LR, Herting J, et al. Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med. 2019;199(7):863–72. https://doi.org/10.1164/rccm.201807-1346OC.
Funding
None.
Author information
Authors and Affiliations
Contributions
TDA created the article outline, performed the literature review, and wrote the manuscript. PPS participated in the literature review and drafting of the manuscript. HBK reviewed and edited the manuscript. RDS conceptualized the article and reviewed and edited the manuscript. The final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflicts of Interest
The authors have no conflicts of interest
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Azad, T.D., Shah, P.P., Kim, H.B. et al. Endotypes and the Path to Precision in Moderate and Severe Traumatic Brain Injury. Neurocrit Care 37 (Suppl 2), 259–266 (2022). https://doi.org/10.1007/s12028-022-01475-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-022-01475-6